Other languages Xencor, Inc.

Equities

XNCR

US98401F1057

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-25 EDT			5-day change	1st Jan Change
19.35 ^USD	-3.68%		-0.46%	-8.86%

06-14	Raymond James Adjusts Price Target on Xencor to $40 From $58, Maintains Strong Buy Rating	MT
06-14	BMO Capital Adjusts Xencor's Price Target to $32 From $34, Keeps Outperform Rating	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Xencor, Inc. Regains CD20 x CD3 Bispecific T-Cell Engager	06-13
Xencor, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09
Xencor Names Bart Cornelissen as Chief Financial Officer	04-09
Xencor Appoints Bart Cornelissen as Senior Vice President	04-09
Xencor Insider Sold Shares Worth $293,519, According to a Recent SEC Filing	03-07
Xencor, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-27
Xencor Insider Sold Shares Worth $1,048,743, According to a Recent SEC Filing	02-14
Xencor, Inc. Appoints Dane Leone as Senior Vice President, Corporate Strategy	01-02
Xencor Insider Sold Shares Worth $941,670, According to a Recent SEC Filing	12-29
Xencor, Inc. Enters into an Amended and Restated Collaboration and License Agreement with Genentech, Inc	11-15
Xencor, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-07
Xencor, Inc. and OCM Life Sciences Portfolio LP, Entere into A Royalty Purchase Agreement	11-07
Xencor Says Cancer Drug Candidates Showed Anti-Tumor Activity in Preclinical Trials	11-03
Xencor Says CFO John Kuch to Retire in March	23-10-26
Xencor Announces Planned Retirement of Senior Vice President John Kuch	23-10-26
Xencor, Inc. Appoints Barbara J. Klencke to Board of Directors	23-09-19
Xencor, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-03
Insider Sell: Xencor	23-06-22
Xencor, Inc. Presents Clinical Results from Phase 1a Study of XmAb®564 at the EULAR 2023 Congress	23-05-30
Xencor Reports Q1 Loss, Lower Revenue	23-05-08

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Xencor, Inc.

Equities

XNCR

US98401F1057

Other languages

Filters